Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimantadine added to pegylated interferon and ribavirin for genotype 1 hepatitis C
2011-002781-21Phase 2Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rimantadine in hepatitis C virus infection (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Rimantadine-specific alterations in HCV genomic sequence. Started Jan 2012; status: completed.
02
Drugs
rimantadine
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-002781-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002781-21.